Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68323305 | 6832330 | 5 | F | 20051120 | 20160912 | 20081204 | 20160916 | EXP | AU-MERCK-0811AUS00195 | MERCK | 13.76 | YR | F | Y | 40.00000 | KG | 20160916 | MD | IT | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68323305 | 6832330 | 1 | PS | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 4 MG, QD | 3052 | MG | N | 20830 | 4 | MG | CHEWABLE TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 68323305 | 6832330 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 68323305 | 6832330 | HO |
| 68323305 | 6832330 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 68323305 | 6832330 | Abnormal behaviour | |
| 68323305 | 6832330 | Aggression | |
| 68323305 | 6832330 | Intentional self-injury | |
| 68323305 | 6832330 | Theft |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 68323305 | 6832330 | 1 | 20031020 | 20060814 | 0 |